Á¦37ȸ ´ëÇÑÁ¤¸ÆÇÐȸ Ãá°èÇмú´ëȸ : 2019-04-07±³À°ÀÏÀÚ : 2019-04-07
±³À°Àå¼Ò : ÀÍ»ê ¿þ½ºÅ϶óÀÌÇÁ È£ÅÚ & ÄÁº¥¼Ç
±³À°ÁÖÁ¦ :
Á¦37ȸ ´ëÇÑÁ¤¸ÆÇÐȸ Ãá°èÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇÑÇ÷°ü¿Ü°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÁ¤¸ÆÇÐȸ
´ã´çÀÚ : ÃÖ¹ÌÁ¤
¿¬¶ôó : 02-3446-9180
À̸ÞÀÏ :
ksp@koreavein.or.kr ±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ½Å°æ¿Ü°ú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
Àü¶óºÏµµ±³À°½Ã°£ : 6 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í ±¸ºÐ»çÀüµî·Ï´çÀϵî·ÏÁ¤È¸¿ø3¸¸¿ø 5¸¸¿ø Àü¹®ÀÇ/ ÀϹÝÀÇ/ °³¿øÀÇ 5¸¸¿ø 8¸¸¿ø ÁÂÀå/¿¬ÀÚ/ Àü°øÀÇ/ºñÀü¹®ÀÇ/Æгθé Á¦ ¸é Á¦
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 04-07 08:30~08:55 Registration ()
±âŸ 04-07 ±×·£µåº¼·ë 08:55~09:00 Opening Address È«±âÇ¥(´ëÇÑÁ¤¸ÆÇÐȸ ÀÌ»çÀå)
±³À°½Ã°£ 04-07 ±×·£µåº¼·ë 09:00~09:10 Lessons ATTRACT trial and the Role of Pharmacomechanical Thrombectomy? ³ë¿µ³²(°è¸í´ë µ¿»êÀÇ·á¿ø)
±³À°½Ã°£ 04-07 ±×·£µåº¼·ë 09:10~09:30 Endovascular Management of IVC filter related complications Liu XiaoBing China(Shanghai No.9 Hospital)
±³À°½Ã°£ 04-07 ±×·£µåº¼·ë 09:30~09:40 Who is indicated for extended anticoagulation in patient with DVT? ±èÇâ°æ(Á߾Ӵ뺴¿ø)
Åä·Ð 04-07 ±×·£µåº¼·ë 09:40~10:00 Discussion ()
ÈÞ½Ä 04-07 ±×·£µåº¼·ë 10:00~10:10 Coffee Break ()
±³À°½Ã°£ 04-07 ±×·£µåº¼·ë 10:10~11:00 Live case of Venaseal º¯½ÂÀç ±è¿µ±Õ(¿ø±¤´ëº´¿ø ´ëÀü¼±º´¿ø)
±³À°½Ã°£ 04-07 ±×·£µåº¼·ë 11:00~11:10 Current data of Venaseal ȲÁ¤±â(°¡Å縯´ë ÀºÆò¼º¸ðº´¿ø)
±³À°½Ã°£ 04-07 ±×·£µåº¼·ë 11:10~11:20 How to manage thrombophlebitis, EGIT and allergic reaction Á¶ÁøÇö(°µ¿°æÈñ´ëº´¿ø)
±³À°½Ã°£ 04-07 ±×·£µåº¼·ë 11:20~12:10 Live case of Clarivein ¹ÚÀμö ±è¹ÌÁø(ÂüÇÏÁö¿Ü°ú ¿¹¼öº´¿ø)
±³À°½Ã°£ 04-07 ±×·£µåº¼·ë 12:10~12:20 Current data of Clarivein ȲȫÇÊ(ÀüºÏ´ëº´¿ø)
±³À°½Ã°£ 04-07 ±×·£µåº¼·ë 12:20~12:30 Ultrasound-Guided Foam Sclerotherapy for Incompetent Saphenous Vein È«±âÇ¥(±¹¹Î°Ç°º¸Çè Àϻ꺴¿ø)
±âŸ 04-07 ±×·£µåº¼·ë 12:30~13:30 Luncheon Session ()
±âŸ 04-07 ±×·£µåº¼·ë 13:00~13:20 ÃÑȸ ¹ÚÁ¾±Ç(´ëÇÑÁ¤¸ÆÇÐȸ ȸÀå)
±âŸ 04-07 ±×·£µåº¼·ë 13:30~14:00 ±â³ä»çÁø ÃÔ¿µ ()
±³À°½Ã°£ 04-07 ±×·£µåº¼·ë 14:00~14:30 Free Papers ±èÇüÅ ȫ±âÇ¥(°è¸í´ëº´¿ø ±¹¹Î°Ç°º¸Çè Àϻ꺴¿ø)
±³À°½Ã°£ 04-07 ±×·£µåº¼·ë 14:30~15:20 Live case of RFA Á¤Àθñ º¯½ÂÀç(º¸¶ó¸Åº´¿ø ¿ø±¤´ëº´¿ø)
±³À°½Ã°£ 04-07 ±×·£µåº¼·ë 15:20~15:30 Thermal ablation and Tumescent techniques À±»óö(¼øõÇâ´ë ¼¿ïº´¿ø)
±³À°½Ã°£ 04-07 ±×·£µåº¼·ë 15:30~15:40 Pros and Cons of Thermal and Non Thermal Ablation ¹Ú±âÇõ(´ë±¸°¡Å縯´ëº´¿ø)
ÈÞ½Ä 04-07 ±×·£µåº¼·ë 15:40~15:50 Coffee Break ()
±³À°½Ã°£ 04-07 ±×·£µåº¼·ë 15:50~16:00 Diagnosis and Treatment of Klippel–Trénaunay syndrome ¾È»óÇö(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 04-07 ±×·£µåº¼·ë 16:00~16:10 Differential Diagnosis of Hemangioma and Venous Malformation ¹Ú¼øö(°¡Å縯´ë ¼¿ï¼º¸ðº´¿ø)
±³À°½Ã°£ 04-07 ±×·£µåº¼·ë 16:10~16:20 Indication and surgical treatment of venous malformation Á¤È£À±(°æºÏ´ëº´¿ø)
Åä·Ð 04-07 ±×·£µåº¼·ë 16:20~16:30 Discussion ()
±³À°½Ã°£ 04-07 ±×·£µåº¼·ë 16:30~17:20 Live case of EVLA with 1940 nm Á¦°¥Àç±â ±è¹ÌÁø(´ÚÅÍ·ùÈäºÎ¿Ü°ú ¿¹¼öº´¿ø)
±³À°½Ã°£ 04-07 ±×·£µåº¼·ë 17:20~17:30 Current data of EVLA ¹Ú¿ë¹ü(û¸Æ¿Ü°ú)
±³À°½Ã°£ 04-07 ±×·£µåº¼·ë 17:30~17:40 Technical advances of EVLA À̰溹(¼¿ïÀÇ·á¿ø)
±âŸ 04-07 ±×·£µåº¼·ë 17:40~17:50 Closing Address È«±âÇ¥(´ëÇÑÁ¤¸ÆÇÐȸ ÀÌ»çÀå)